SA

Siddharth Anirudhbhai Narela

Active Director Director DIN 10771713
DIN 10771713 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Siddharth Anirudhbhai Narela

Data last updated:

Siddharth Anirudhbhai Narela is a Director at Riveca Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10771713
Primary Designation Director
Industry Pharma
First Appointment 07 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Sep 20242024Active

Board colleagues of Siddharth Anirudhbhai Narela

Directorship timeline

Open interactive timeline →
Riveca Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Siddharth Anirudhbhai Narela

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddharth Anirudhbhai Narela

Siddharth Anirudhbhai Narela currently holds 1 directorship: Riveca Pharmaceuticals Private Limited (Director, since 07 Sep 2024).

Siddharth Anirudhbhai Narela was first appointed on 07 Sep 2024 as Director at Riveca Pharmaceuticals Private Limited.

The current boards of Siddharth Anirudhbhai Narela's companies include Sureshchandra Manilal Patel (Riveca Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available